Salience network and parahippocampal dopamine dysfunction in memory-impaired parkinson disease

Annals of Neurology

Volumn 77, Issue 2, 2015, Pages 269-280

  Christopher, Leigh ^a,b,c   Duff Canning, Sarah ^a   Koshimori, Yuko ^a,b,c   Segura, Barbara ^b,c,d   Boileau, Isabelle ^b   Chen, Robert ^a   Lang, Anthony E ^a   Houle, Sylvain ^b   Rusjan, Pablo ^b   Strafella, Antonio P ^a,b,c  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; ISOREMOXIPRIDE C 11; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; DOPAMINE 2 RECEPTOR; PROTEIN BINDING;

AGED; AMNESIA; ANTERIOR CINGULATE; ARTICLE; BRAIN DYSFUNCTION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE SEVERITY; DOPAMINERGIC NERVE CELL; EXECUTIVE FUNCTION; FEMALE; HIPPOCAMPUS; HUMAN; INSULA; MALE; MEMORY DISORDER; NERVE CELL DEGENERATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE SCANNER; PARAHIPPOCAMPAL GYRUS; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BINDING; SALIENCE NETWORK; METABOLISM; MIDDLE AGED; NERVE CELL NETWORK; PHYSIOLOGY; PROCEDURES; SCINTISCANNING;

AGED; DOPAMINE; DOPAMINERGIC NEURONS; FEMALE; HUMANS; MALE; MEMORY DISORDERS; MIDDLE AGED; NERVE NET; PARAHIPPOCAMPAL GYRUS; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; RECEPTORS, DOPAMINE D2;

EID: 84922808708     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24323     Document Type: Article

References (73)

1. Levy G, Jacobs DM, Tang M-X, et al. Memory and executive function impairment predict dementia in Parkinson disease. Mov Disord 2002;17:1221-1226.
2. Pedersen KF, Larsen JP, Tysnes O-B, Alves G. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study. JAMA Neurol 2013;70:580-586.
3. Shohamy D, Adcock RA. Dopamine and adaptive memory. Trends Cogn Sci 2010;14:464-472.
4. Apitz T, Bunzeck N. Dopamine controls the neural dynamics of memory signals and retrieval accuracy. Neuropsychopharmacology 2013;38:2409-2417.
5. Lisman JE, Grace AA. The hippocampal-VTA loop: controlling the entry of information into long-term memory. Neuron 2005;46:703-713.
6. Christopher L, Marras C, Duff-Canning S, et al. Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson disease with mild cognitive impairment. Brain 2014;137(pt 2):565-575.
7. Sridharan D, Levitin DJ, Menon V. A critical role for the right fronto-insular cortex in switching between central-executive and default-mode networks. Proc Natl Acad Sci U S A 2008;105:12569-12574.
8. Chiong W, Wilson SM, D'Esposito M, et al. The salience network causally influences default mode network activity during moral reasoning. Brain 2013;136(pt 6):1929-1941.
9. Bonnelle V, Ham TE, Leech R, et al. Salience network integrity predicts default mode network function after traumatic brain injury. Proc Natl Acad Sci U S A 2012;109:4690-4695.
10. Blumenfeld RS, Ranganath C. Dorsolateral prefrontal cortex promotes long-term memory formation through its role in working memory organization. J Neurosci 2006;26:916-925.
11. Huijbers W, Pennartz CM, Cabeza R, Daselaar SM. The hippocampus is coupled with the default network during memory retrieval but not during memory encoding. PLoS One 2011;6:e17463.
12. Dobbins IG, Foley H, Schacter DL, Wagner AD. Executive control during episodic retrieval: multiple prefrontal processes subserve source memory. Neuron 2002;35:989-996.
13. Wagner AD, Shannon BJ, Kahn I, Buckner RL. Parietal lobe contributions to episodic memory retrieval. Trends Cogn Sci 2005;9:445-453.
14. Anderson MC, Green C. Suppressing unwanted memories by executive control. Nature 2001;410:366-369.
15. Kolbjørn B, Guido A, Dag A, et al. Verbal memory in drug-naive, newly diagnosed Parkinson disease. The retrieval deficit hypothesis revisited. Neuropsychology 2011;25:114-124.
16. Chikama M, McFarland NR, Amaral DG, Haber SN. Insular cortical projections to functional regions of the striatum correlate with cortical cytoarchitectonic organization in the primate. J Neurosci 1997;17:9686-9705.
17. Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 1990;13:266-271.
18. Costa C, Sgobio C, Siliquini S, et al. Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson disease. Brain 2012;135(pt 6):1884-1899.
19. Calabresi P, Castrioto A, Di Filippo M, Picconi B. New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson disease. Lancet Neurol 2013;12:811-821.
20. Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson disease Mov Disord 2007;22:1689-1707.
21. Evans AH, Katzenschlager R, Paviour D, et al. Punding in Parkinson disease: its relation to the dopamine dysregulation syndrome. Mov Disord 2004;19:397-405.
22. Beck A, Ward C, Mendelson M, et al. Inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
23. Frey KA, Koeppe RA, Kilbourn MR, et al. Presynaptic monoaminergic vesicles in Parkinson disease and normal aging. Ann Neurol 1996;40:873-884.
24. Bohnen NI, Albin RL, Koeppe RA, et al. Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease. J Cereb Blood Flow Metab 2006;26:1198-1212.
25. Martin WRW, Wieler M, Stoessl AJ, Schulzer M. Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson disease. Ann Neurol 2008;63:388-394.
26. Stoessl AJ. Neuroimaging in Parkinson disease. Neurotherapeutics 2011;8:72-81.
27. Litvan I, Goldman JG, Tröster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson disease: Movement Disorder Society Task Force guidelines. Mov Disord 2012;27:349-356.
28. Reeves S, Mehta M, Howard R, et al. The dopaminergic basis of cognitive and motor performance in Alzheimer's disease. Neurobiol Dis 2010;37:477-482.
29. Beyer MK, Janvin CC, Larsen JP, Aarsland D. A magnetic resonance imaging study of patients with Parkinson disease with mild cognitive impairment and dementia using voxel-based morphometry 2007;78:254-259.
30. Cools R, Altamirano L, D'Esposito M. Reversal learning in Parkinson disease depends on medication status and outcome valence. Neuropsychologia 2006;44:1663-1673.
31. Wicklund AH, Johnson N, Weintraub S. Preservation of reasoning in primary progressive aphasia: further differentiation from Alzheimer's disease and the behavioral presentation of frontotemporal dementia. J Clin Exp Neuropsychol 2004;26:347-355.
32. Herwig U, Kaffenberger T, Jöncke L, Brühl AB. Self-related awareness and emotion regulation. Neuroimage 2010;50:734-741.
33. Hodges JR, Salmon DP, Butters N. Semantic memory impairment in Alzheimer's disease: failure of access or degraded knowledge? Neuropsychologia 1992;30:301-314.
34. Meyers JE, Meyers KR. Rey complex figure test and recognition trial - professional manual. Odessa, FL: Psychological Assessment Resources, 1995.
35. Williams BW, Wendy MACK, Henderson VW, Mack W. Boston naming test in Alzheimer's disease. Neuropsychologia 1989;27:1073-1079.
36. Pike KE, Savage G, Villemagne VL, et al. Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain 2007;130(pt 11):2837-2844.
37. Miller SL, Celone K, Depeau K, et al. Age-related memory impairment associated with loss of parietal deactivation but preserved hippocampal activation. Proc Natl Acad Sci U S A 2007;105:2181-2186.
38. Defrise M, Kinahan PE, Townsend DW, et al. Exact and approximate rebinning algorithms for 3-D PET data. IEEE Trans Med Imaging 1997;16:145-158.
39. Collins D, Neelin P, Peters T, Evans A. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr 1994;18:192-205.
40. Woods RP, Mazziotta JC, Cherry SR. MRI-PET registration with automated algorithm. J Comput Assist Tomogr 1993;17:536-546.
41. Gunn R, Lammertsma A, Hume S, Cunningham V. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 1997;6:279-287.
42. Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage 1996;4(3 pt 1):153-158.
43. Aston JA, Gunn RN, Worsley KJ, et al. A statistical method for the analysis of positron emission tomography neuroreceptor ligand data. Neuroimage 2000;12:245-256.
44. Boileau I, Rusjan P, Houle S, et al. Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: is VMAT2 a stable dopamine neuron biomarker? J Neurosci 2008;28:9850-9856.
45. Rusjan P, Mamo D, Ginovart N, et al. An automated method for the extraction of regional data from PET images. Psychiatry Res 2006;147:79-89.
46. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. New York, NY: Thieme Medical Publishers, 1988.
47. Kabani NJ, Collins DL, Evans AC. A 3d neuroanatomical atlas. Paper presented at: 4th International Conference on Functional Mapping of the Human Brain; June 7-12, 1998; Montreal, Quebec, Canada.
48. Mawlawi O, Martinez D, Slifstein M, et al. Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab 2001;21:1034-1057.
49. Scherman D, Raisman R, Ploska A, Agid Y. [3H]dihydrotetrabenazine, a new in vitro monoaminergic probe for human brain. J Neurochem 1988;50:1131-1136.
50. Koeppe RA, Frey KA, Vander Borght TM, et al. Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter. J Cereb Blood Flow Metab 1996;16:1288-1299.
51. Chan GL, Holden JE, Stoessl AJ, et al. Reproducibility studies with 11C-DTBZ, a monoamine vesicular transporter inhibitor in healthy human subjects. J Nucl Med 1999;40:283-289.
52. Rousset OG, Ma Y, Evans AC. Correction for partial volume effects in PET: principle and validation. J Nucl Med 1998;39:904-911.
53. Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 1999;9:179-194.
54. Fischl B, Sereno MI, Dale AM. Cortical surface-based analysis. II. Inflation, flattening, and a surface-based coordinate system. Neuroimage 1999;9:195-207.
55. Fischl B, Dale A. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A 2000;9:11050-11055.
56. Seeley WW, Crawford RK, Zhou J, et al. Neurodegenerative diseases target large-scale human brain networks. Neuron 2009;62:42-52.
57. Seeley WW, Menon V, Schatzberg AF, et al. Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci 2007;27:2349-2356.
58. Menon V, Uddin LQ. Saliency, switching, attention and control: a network model of insula function. Brain Struct Funct 2010;214:655-667.
59. Dhanjal NS, Wise RJS. Frontoparietal cognitive control of verbal memory recall in Alzheimer's disease. Ann Neurol 2014;76:241-251.
60. Andrews-Hanna JR, Reidler JS, Sepulcre J, et al. Functional-anatomic fractionation of the brain's default network. Neuron 2010;65:550-562.
61. Diana RA, Yonelinas AP, Ranganath C. Imaging recollection and familiarity in the medial temporal lobe: a three-component model. Trends Cogn Sci 2007;11:379-386.
62. Wagner AD. Building memories: remembering and forgetting of verbal experiences as predicted by brain activity. Science 1998;281:1188-1191.
63. Bohbot VD, Kalina M, Stepankova K, et al. Spatial memory deficits in patients with lesions to the right hippocampus and to the right parahippocampal cortex. Neuropsychologia 1998;36:1217-1238.
64. Owen AM, Milner B, Petrides M, Evans AC. A specific role for the right parahippocampal gyrus in the retrieval of object-location: a positron emission tomography study. J Cogn Neurosci 1996;8:588-602.
65. Ward AM, Schultz AP, Huijbers W, et al. The parahippocampal gyrus links the default-mode cortical network with the medial temporal lobe memory system. Hum Brain Mapp 2014;35:1061-1073.
66. Singer T, Critchley HD, Preuschoff K. A common role of insula in feelings, empathy and uncertainty. Trends Cogn Sci 2009;13:334-340.
67. Levy BJ, Anderson MC. Inhibitory processes and the control of memory retrieval. Trends Cogn Sci 2002;6:299-305.
68. Braak H, Bohl JR, Müller CM, et al. Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson disease reconsidered. Mov Disord 2006;21:2042-2051.
69. Kaasinen V, Aalto S, Nagren K, et al. Extrastriatal dopamine D(2) receptors in Parkinson disease: a longitudinal study. J Neural Transm 2003;110:591-601.
70. Seamans JK, Yang CR. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 2004;74:1-58.
71. Gomperts SN, Locascio JJ, Rentz D, et al. Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia. Neurology 2013;80:85-91.
72. Tsukada H, Harada N, Nishiyama S, et al. Cholinergic neuronal modulation alters dopamine D2 receptor availability in vivo by regulating receptor affinity induced by facilitated synaptic dopamine turnover: positron emission tomography studies with microdialysis in the conscious monkey brain. J Neurosci 2000;20:7067-7073.
73. Taylor A, Saint-Cyr J, Lang A. Memory and learning in early Parkinson disease: evidence for a "frontal lobe syndrome." Brain Cogn 1990;13:211-232.